Jazz Pharmaceuticals (JAZZ) EPS (Basic) (2010 - 2026)
Jazz Pharmaceuticals (JAZZ) posted quarterly EPS (Basic) of $4.74 for Q1 2026, up 412.61% year-over-year from $0.92 in Q1 2025, and up 41.88% quarter-over-quarter from $3.34 in Q4 2025.
Jazz Pharmaceuticals (JAZZ) EPS (Basic) (2010 - 2026) Analysis & Trends
Jazz Pharmaceuticals' EPS (Basic) history runs 16 years deep, the most recent figure standing at $4.74 for Q1 2026.
- In Q1 2026, EPS (Basic) rose 412.61% year-over-year to $4.74; the TTM figure through Mar 2026 stood at $0.48 (down 93.94% YoY), while the FY2025 annual figure was -$5.83, down 164.16% from the prior year.
- EPS (Basic) for Q1 2026 stood at $4.74, up from $3.34 in the prior quarter.
- The five-year high for EPS (Basic) was $4.74 in Q1 2026, with the low at -$11.74 in Q2 2025.
- The 5-year median for EPS (Basic) is $1.5 (2023), against an average of $0.66.
- The sharpest annual moves came in 2022 and 2023: EPS (Basic) tumbled 607.71% in 2022, then soared 1085.32% in 2023.
- Jazz Pharmaceuticals' EPS (Basic) stood at -$3.84 in 2022, then surged by 138.97% to $1.5 in 2023, then jumped by 106.75% to $3.09 in 2024, then grew by 7.97% to $3.34 in 2025, then surged by 41.88% to $4.74 in 2026.
- Business Quant data shows JAZZ's EPS (Basic) at $4.74 in Q1 2026, $3.34 in Q4 2025, and $4.14 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Jazz Pharmaceuticals | 15.90 Bn | 14.28 Bn | 1.09 Bn | 3.05 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.05 |
| Mar 31, 2026 | 4.74 |
| Dec 31, 2025 | 3.34 |
| Sep 30, 2025 | 4.14 |
| Jun 30, 2025 | -11.74 |
| Mar 31, 2025 | -1.51 |
| Dec 31, 2024 | 3.09 |
| Sep 30, 2024 | 3.51 |
| Jun 30, 2024 | 2.68 |
| Mar 31, 2024 | -0.23 |
| Dec 31, 2023 | 1.50 |
| Sep 30, 2023 | 2.32 |
| Jun 30, 2023 | 1.66 |
| Mar 31, 2023 | 1.11 |
| Dec 31, 2022 | -3.84 |
| Sep 30, 2022 | -0.27 |
| Jun 30, 2022 | 0.59 |
| Mar 31, 2022 | 0.09 |
| Dec 31, 2021 | -0.54 |
| Sep 30, 2021 | -0.81 |